nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfadiazine—CYP2E1—Parkinson's disease	0.959	1	CbGaD
Sulfadiazine—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—Parkinson's disease	0.00092	0.0231	CbGpPWpGaD
Sulfadiazine—CYP2E1—Fatty Acid Omega Oxidation—CYP2D6—Parkinson's disease	0.000895	0.0225	CbGpPWpGaD
Sulfadiazine—CYP2E1—Folate-Alcohol and Cancer Pathway—MTHFR—Parkinson's disease	0.000868	0.0218	CbGpPWpGaD
Sulfadiazine—CYP2C9—CYP2E1 reactions—CYP2D6—Parkinson's disease	0.000849	0.0214	CbGpPWpGaD
Sulfadiazine—CYP2C9—CYP2E1 reactions—CYP2E1—Parkinson's disease	0.000777	0.0195	CbGpPWpGaD
Sulfadiazine—CYP2E1—Xenobiotics—CYP2D6—Parkinson's disease	0.000748	0.0188	CbGpPWpGaD
Sulfadiazine—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Parkinson's disease	0.000723	0.0182	CbGpPWpGaD
Sulfadiazine—CYP2E1—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.00072	0.0181	CbGpPWpGaD
Sulfadiazine—CYP2C8—Xenobiotics—CYP2D6—Parkinson's disease	0.000647	0.0163	CbGpPWpGaD
Sulfadiazine—CYP2C8—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.000622	0.0156	CbGpPWpGaD
Sulfadiazine—CYP2E1—Tryptophan metabolism—DDC—Parkinson's disease	0.000614	0.0155	CbGpPWpGaD
Sulfadiazine—CYP2C8—Xenobiotics—CYP2E1—Parkinson's disease	0.000592	0.0149	CbGpPWpGaD
Sulfadiazine—CYP2C8—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000569	0.0143	CbGpPWpGaD
Sulfadiazine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—Parkinson's disease	0.000557	0.014	CbGpPWpGaD
Sulfadiazine—CYP2C9—Xenobiotics—CYP2D6—Parkinson's disease	0.000526	0.0132	CbGpPWpGaD
Sulfadiazine—CYP2E1—Tryptophan metabolism—MAOB—Parkinson's disease	0.000517	0.013	CbGpPWpGaD
Sulfadiazine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—Parkinson's disease	0.000516	0.013	CbGpPWpGaD
Sulfadiazine—CYP2C9—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.000506	0.0127	CbGpPWpGaD
Sulfadiazine—CYP2C9—Xenobiotics—CYP2E1—Parkinson's disease	0.000482	0.0121	CbGpPWpGaD
Sulfadiazine—CYP2C9—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000463	0.0116	CbGpPWpGaD
Sulfadiazine—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Parkinson's disease	0.000415	0.0104	CbGpPWpGaD
Sulfadiazine—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.00038	0.00955	CbGpPWpGaD
Sulfadiazine—Sulfanilamide—CYP2E1—Parkinson's disease	0.000374	0.277	CrCbGaD
Sulfadiazine—Sulfaphenazole—CYP2D6—Parkinson's disease	0.00037	0.273	CrCbGaD
Sulfadiazine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.00035	0.00879	CbGpPWpGaD
Sulfadiazine—CYP3A4—Xenobiotics—CYP2D6—Parkinson's disease	0.000347	0.00873	CbGpPWpGaD
Sulfadiazine—CYP3A4—Estrogen metabolism—NQO1—Parkinson's disease	0.000342	0.00859	CbGpPWpGaD
Sulfadiazine—CYP2E1—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000339	0.00853	CbGpPWpGaD
Sulfadiazine—CYP3A4—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.000334	0.0084	CbGpPWpGaD
Sulfadiazine—Dapsone—CYP2E1—Parkinson's disease	0.000334	0.247	CrCbGaD
Sulfadiazine—CYP3A4—Xenobiotics—CYP2E1—Parkinson's disease	0.000318	0.00799	CbGpPWpGaD
Sulfadiazine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.000315	0.00792	CbGpPWpGaD
Sulfadiazine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000311	0.00782	CbGpPWpGaD
Sulfadiazine—CYP2E1—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000307	0.00771	CbGpPWpGaD
Sulfadiazine—CYP3A4—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000305	0.00768	CbGpPWpGaD
Sulfadiazine—CYP2C8—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000293	0.00737	CbGpPWpGaD
Sulfadiazine—CYP3A4—Estrogen metabolism—COMT—Parkinson's disease	0.000286	0.0072	CbGpPWpGaD
Sulfadiazine—CYP3A4—Tryptophan metabolism—DDC—Parkinson's disease	0.000285	0.00717	CbGpPWpGaD
Sulfadiazine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—Parkinson's disease	0.000282	0.0071	CbGpPWpGaD
Sulfadiazine—Sulfanilamide—CYP2D6—Parkinson's disease	0.000274	0.203	CrCbGaD
Sulfadiazine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000269	0.00676	CbGpPWpGaD
Sulfadiazine—CYP2C8—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000265	0.00667	CbGpPWpGaD
Sulfadiazine—CYP3A4—Estrogen metabolism—GSTM1—Parkinson's disease	0.000262	0.00659	CbGpPWpGaD
Sulfadiazine—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.000258	0.00649	CbGpPWpGaD
Sulfadiazine—CYP2E1—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000252	0.00634	CbGpPWpGaD
Sulfadiazine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.000246	0.00618	CbGpPWpGaD
Sulfadiazine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000246	0.00618	CbGpPWpGaD
Sulfadiazine—CYP2C8—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000242	0.0061	CbGpPWpGaD
Sulfadiazine—CYP3A4—Tryptophan metabolism—MAOB—Parkinson's disease	0.00024	0.00603	CbGpPWpGaD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000238	0.006	CbGpPWpGaD
Sulfadiazine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000219	0.0055	CbGpPWpGaD
Sulfadiazine—CYP2C8—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000218	0.00548	CbGpPWpGaD
Sulfadiazine—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000216	0.00543	CbGpPWpGaD
Sulfadiazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.000208	0.00522	CbGpPWpGaD
Sulfadiazine—CYP2C8—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.000206	0.00519	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—GSTA4—Parkinson's disease	0.000202	0.00508	CbGpPWpGaD
Sulfadiazine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.0002	0.00503	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000199	0.00501	CbGpPWpGaD
Sulfadiazine—CYP2C8—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000199	0.00501	CbGpPWpGaD
Sulfadiazine—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000197	0.00496	CbGpPWpGaD
Sulfadiazine—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00019	0.00477	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—MAOB—Parkinson's disease	0.00018	0.00453	CbGpPWpGaD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000177	0.00446	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—GSTA4—Parkinson's disease	0.000175	0.00439	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000172	0.00433	CbGpPWpGaD
Sulfadiazine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.00017	0.00428	CbGpPWpGaD
Sulfadiazine—CYP2C9—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.000168	0.00422	CbGpPWpGaD
Sulfadiazine—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000164	0.00412	CbGpPWpGaD
Sulfadiazine—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.000163	0.0041	CbGpPWpGaD
Sulfadiazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.000162	0.00408	CbGpPWpGaD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000162	0.00408	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000157	0.00396	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—MAOB—Parkinson's disease	0.000156	0.00391	CbGpPWpGaD
Sulfadiazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000144	0.00363	CbGpPWpGaD
Sulfadiazine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000142	0.00358	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—GSTA4—Parkinson's disease	0.000142	0.00357	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00014	0.00353	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—CYP2D6—Parkinson's disease	0.000134	0.00337	CbGpPWpGaD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000133	0.00335	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000132	0.00332	CbGpPWpGaD
Sulfadiazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000132	0.00332	CbGpPWpGaD
Sulfadiazine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00013	0.00327	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—MAOB—Parkinson's disease	0.000127	0.00319	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000117	0.00294	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—CYP2D6—Parkinson's disease	0.000116	0.00291	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000114	0.00287	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000107	0.00269	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—CYP2E1—Parkinson's disease	0.000106	0.00266	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000104	0.00262	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—COMT—Parkinson's disease	0.000101	0.00255	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—GSTP1—Parkinson's disease	0.000101	0.00254	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—MAOA—Parkinson's disease	0.000101	0.00253	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metapathway biotransformation—COMT—Parkinson's disease	0.0001	0.00252	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metapathway biotransformation—GSTP1—Parkinson's disease	9.96e-05	0.0025	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	9.67e-05	0.00243	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—CYP2D6—Parkinson's disease	9.41e-05	0.00237	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	9.37e-05	0.00236	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—CYP2D6—Parkinson's disease	9.28e-05	0.00234	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—GSTM1—Parkinson's disease	9.28e-05	0.00233	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	9.24e-05	0.00232	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metapathway biotransformation—GSTM1—Parkinson's disease	9.15e-05	0.0023	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	8.8e-05	0.00221	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—COMT—Parkinson's disease	8.77e-05	0.0022	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—GSTP1—Parkinson's disease	8.72e-05	0.00219	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—MAOA—Parkinson's disease	8.7e-05	0.00219	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metapathway biotransformation—COMT—Parkinson's disease	8.65e-05	0.00217	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—CYP2E1—Parkinson's disease	8.61e-05	0.00217	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metapathway biotransformation—GSTP1—Parkinson's disease	8.6e-05	0.00216	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—CYP2E1—Parkinson's disease	8.49e-05	0.00214	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	8.35e-05	0.0021	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—GSTM1—Parkinson's disease	8.02e-05	0.00202	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metapathway biotransformation—GSTM1—Parkinson's disease	7.91e-05	0.00199	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	7.87e-05	0.00198	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—COMT—Parkinson's disease	7.13e-05	0.00179	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—GSTP1—Parkinson's disease	7.1e-05	0.00179	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—MAOA—Parkinson's disease	7.08e-05	0.00178	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—COMT—Parkinson's disease	7.04e-05	0.00177	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	7e-05	0.00176	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—MCCC1—Parkinson's disease	6.58e-05	0.00165	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ND3—Parkinson's disease	6.58e-05	0.00165	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	6.53e-05	0.00164	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	6.44e-05	0.00162	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	6.21e-05	0.00156	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—TALDO1—Parkinson's disease	6.18e-05	0.00156	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—OMD—Parkinson's disease	6.18e-05	0.00156	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	6.12e-05	0.00154	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	6.04e-05	0.00152	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—NDUFB11—Parkinson's disease	5.86e-05	0.00147	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—MCCC1—Parkinson's disease	5.68e-05	0.00143	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ND3—Parkinson's disease	5.68e-05	0.00143	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	5.68e-05	0.00143	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	5.6e-05	0.00141	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GCH1—Parkinson's disease	5.59e-05	0.00141	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—TALDO1—Parkinson's disease	5.34e-05	0.00134	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—OMD—Parkinson's disease	5.34e-05	0.00134	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—NDUFB11—Parkinson's disease	5.07e-05	0.00127	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—FBP1—Parkinson's disease	4.98e-05	0.00125	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GBA—Parkinson's disease	4.98e-05	0.00125	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—DBH—Parkinson's disease	4.98e-05	0.00125	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	4.91e-05	0.00124	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GCH1—Parkinson's disease	4.83e-05	0.00122	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—COMT—Parkinson's disease	4.71e-05	0.00118	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	4.68e-05	0.00118	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	4.67e-05	0.00118	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	4.64e-05	0.00117	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ND3—Parkinson's disease	4.63e-05	0.00116	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—MCCC1—Parkinson's disease	4.63e-05	0.00116	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	4.62e-05	0.00116	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	4.36e-05	0.0011	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—OMD—Parkinson's disease	4.35e-05	0.00109	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—TALDO1—Parkinson's disease	4.35e-05	0.00109	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—FBP1—Parkinson's disease	4.31e-05	0.00108	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—DBH—Parkinson's disease	4.31e-05	0.00108	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GBA—Parkinson's disease	4.31e-05	0.00108	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	4.3e-05	0.00108	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	4.24e-05	0.00107	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	4.12e-05	0.00104	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GCH1—Parkinson's disease	3.93e-05	0.000989	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—DDC—Parkinson's disease	3.66e-05	0.00092	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	3.55e-05	0.000892	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GBA—Parkinson's disease	3.51e-05	0.000882	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—FBP1—Parkinson's disease	3.51e-05	0.000882	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—DBH—Parkinson's disease	3.51e-05	0.000882	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GSTA4—Parkinson's disease	3.45e-05	0.000869	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—DDC—Parkinson's disease	3.16e-05	0.000795	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PLA2G6—Parkinson's disease	3.11e-05	0.000782	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—MAOB—Parkinson's disease	3.08e-05	0.000774	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ND3—Parkinson's disease	3.05e-05	0.000767	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—MCCC1—Parkinson's disease	3.05e-05	0.000767	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GSTA4—Parkinson's disease	2.99e-05	0.000751	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.95e-05	0.000742	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—TALDO1—Parkinson's disease	2.87e-05	0.000722	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—OMD—Parkinson's disease	2.87e-05	0.000722	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	2.72e-05	0.000684	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PLA2G6—Parkinson's disease	2.69e-05	0.000676	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—MAOB—Parkinson's disease	2.66e-05	0.000669	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GCH1—Parkinson's disease	2.59e-05	0.000653	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—DDC—Parkinson's disease	2.57e-05	0.000647	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.53e-05	0.000637	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTA4—Parkinson's disease	2.43e-05	0.000611	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.4e-05	0.000604	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—FBP1—Parkinson's disease	2.31e-05	0.000582	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—DBH—Parkinson's disease	2.31e-05	0.000582	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GBA—Parkinson's disease	2.31e-05	0.000582	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP2D6—Parkinson's disease	2.29e-05	0.000576	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CTGF—Parkinson's disease	2.25e-05	0.000565	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	2.19e-05	0.00055	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—MAOB—Parkinson's disease	2.17e-05	0.000545	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—NQO1—Parkinson's disease	2.07e-05	0.000521	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.06e-05	0.000519	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—TH—Parkinson's disease	2.04e-05	0.000513	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP2D6—Parkinson's disease	1.98e-05	0.000498	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYCS—Parkinson's disease	1.96e-05	0.000493	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CTGF—Parkinson's disease	1.94e-05	0.000488	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP2E1—Parkinson's disease	1.81e-05	0.000455	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—NQO1—Parkinson's disease	1.79e-05	0.00045	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—TH—Parkinson's disease	1.76e-05	0.000443	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—COMT—Parkinson's disease	1.73e-05	0.000436	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GSTP1—Parkinson's disease	1.73e-05	0.000434	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—MAOA—Parkinson's disease	1.72e-05	0.000433	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—HMOX1—Parkinson's disease	1.7e-05	0.000428	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—DDC—Parkinson's disease	1.7e-05	0.000427	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYCS—Parkinson's disease	1.69e-05	0.000426	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ABCB1—Parkinson's disease	1.63e-05	0.000411	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	1.61e-05	0.000405	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.6e-05	0.000403	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GSTM1—Parkinson's disease	1.59e-05	0.000399	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CTGF—Parkinson's disease	1.58e-05	0.000397	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GPX1—Parkinson's disease	1.52e-05	0.000382	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—COMT—Parkinson's disease	1.5e-05	0.000377	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GSTP1—Parkinson's disease	1.49e-05	0.000375	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—MAOA—Parkinson's disease	1.49e-05	0.000374	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	1.47e-05	0.00037	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—HMOX1—Parkinson's disease	1.47e-05	0.00037	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—NQO1—Parkinson's disease	1.46e-05	0.000366	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.44e-05	0.000363	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—TH—Parkinson's disease	1.43e-05	0.000361	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.43e-05	0.000359	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ABCB1—Parkinson's disease	1.41e-05	0.000355	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—MTHFR—Parkinson's disease	1.4e-05	0.000353	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYCS—Parkinson's disease	1.38e-05	0.000347	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GSTM1—Parkinson's disease	1.37e-05	0.000345	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GPX1—Parkinson's disease	1.31e-05	0.00033	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—APOE—Parkinson's disease	1.31e-05	0.000328	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—COMT—Parkinson's disease	1.22e-05	0.000307	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTP1—Parkinson's disease	1.21e-05	0.000305	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—MTHFR—Parkinson's disease	1.21e-05	0.000305	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—MAOA—Parkinson's disease	1.21e-05	0.000305	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—HMOX1—Parkinson's disease	1.2e-05	0.000301	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ABCB1—Parkinson's disease	1.15e-05	0.000289	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—APOE—Parkinson's disease	1.13e-05	0.000284	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTM1—Parkinson's disease	1.12e-05	0.000281	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—INS—Parkinson's disease	1.11e-05	0.00028	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GPX1—Parkinson's disease	1.07e-05	0.000269	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.06e-05	0.000267	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.04e-05	0.000262	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—MTHFR—Parkinson's disease	9.86e-06	0.000248	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	9.71e-06	0.000244	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—INS—Parkinson's disease	9.64e-06	0.000242	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—NQO1—Parkinson's disease	9.6e-06	0.000242	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—TH—Parkinson's disease	9.46e-06	0.000238	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—APOE—Parkinson's disease	9.18e-06	0.000231	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYCS—Parkinson's disease	9.09e-06	0.000229	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—COMT—Parkinson's disease	8.05e-06	0.000202	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTP1—Parkinson's disease	8.01e-06	0.000201	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—MAOA—Parkinson's disease	7.99e-06	0.000201	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—HMOX1—Parkinson's disease	7.9e-06	0.000199	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—INS—Parkinson's disease	7.84e-06	0.000197	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ABCB1—Parkinson's disease	7.58e-06	0.000191	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTM1—Parkinson's disease	7.36e-06	0.000185	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GPX1—Parkinson's disease	7.05e-06	0.000177	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—MTHFR—Parkinson's disease	6.5e-06	0.000164	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—APOE—Parkinson's disease	6.06e-06	0.000152	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—INS—Parkinson's disease	5.17e-06	0.00013	CbGpPWpGaD
